Your Labs Are Normal But You Still Feel Sick? Here’s Why

I want to tell you about a woman I’ll call Rachel.

Rachel spent four years and thousands of dollars trying to lose weight that would not move. She counted calories. She ran. She saw doctor after doctor — her primary care provider, a weight management specialist, a second opinion she paid out of pocket for — and heard some version of the same thing each time. She was told, more than once, that she was probably eating more than she thought she was — the polite clinical phrasing for “we don’t believe you.” Eventually a provider suggested a GLP-1 medication and left it there, as if the prescription itself were the diagnosis.

What never came up in any of those visits was the fatigue that had become her baseline, or the gut symptoms she’d quietly stopped mentioning because no one seemed to connect them to anything: the diarrhea some mornings and constipation others, the bloating that made her look pregnant by early afternoon, the heartburn she’d started treating with an over-the-counter medication every single night. She’d come to think of all of it as just how her body was now.

Nobody asked what her body was reacting to.

When we ran her MRT, the picture became clear almost immediately. Rachel wasn’t overeating. She was inflamed — chronically, silently, systemically inflamed by a handful of foods she ate daily and considered healthy. Once we removed her specific reactive foods and calmed that immune response, her weight began to shift for the first time in years, without a restrictive diet and without more willpower than she’d already been showing all along. The fatigue lifted within weeks. The diarrhea, the bloating, and the heartburn — three separate symptoms she’d never once heard connected to each other — resolved together, because they’d never been three separate problems. They were one inflamed gut, expressing itself three different ways. Her body wasn’t broken. It was reacting to something no one had ever measured.

I share Rachel’s story — details changed, identity protected, as I do with every client story I share publicly — because it is not rare. It is the pattern I see over and over in 26 years of clinical practice. And I think it points to something healthcare needs to reckon with.

What “Average” Actually Means (And Why It Doesn’t Mean You)

Here’s a plain-language way to picture it. Imagine a room of 100 people who all tried the same treatment for the same condition. If you lined them up by how much they improved — “no change at all” on one end of the room, “completely better” on the other — most of them would end up clustered somewhere in the middle. That’s just how groups of people tend to sort themselves out.

If you turned that lineup into a graph — how many people landed at each point, from one end of the room to the other — it would form a shape like a hill: low on both ends, rising to a peak in the middle. That shape is what’s called a “bell curve,” because it’s shaped roughly like a bell. The peak of that hill is the “average” result. It’s not a real person. It’s just where the crowd happens to cluster.

Now here’s the part that matters. A clinical trial is built to describe that hill — the peak, the cluster, the typical response. It is genuinely useful for that. Randomized controlled trials, meta-analyses, large cohort studies — these tools have saved millions of lives, and I use the evidence base constantly in my own practice. I am not asking anyone to throw that out.

But a trial was never built to describe the people standing at the edges of the room — and there are always people at the edges. It tells you what happens to the typical participant, under the exact conditions the study was designed to test. It was never built to tell you what happens to you — a specific person with a specific immune system, a specific gut microbiome, a specific history of inflammation, stress, and exposures that no study group perfectly replicates.

In plain terms: if you gathered everyone who has ever tried a given treatment, roughly a third of them would have a real, measurable response that looks nothing like the “average” result reported in the study. Not because they’re exceptions, or because something is wrong with them — because averages, by definition, always leave people standing outside them. That’s not a fringe case. That’s tens of millions of people whose real, measurable, meaningful improvement doesn’t show up as a blip on someone else’s hill-shaped graph — because it was never going to. When a person’s actual lived experience of feeling dramatically better gets waved off because it doesn’t match the group average, we’ve mistaken the map for the territory.

I built the graphic below to make this concrete. This is what it looks like when a person’s real result sits well outside where the average would predict.

None of this means data doesn’t matter. It means data describes a group, and you are not a group. You are one person, with one body, and you deserve a clinician who can hold both truths at once: what the research shows in general, and what your own body is telling us in particular.

When “There’s No Data For That” Becomes a Way to Stop Listening

I hear a version of the same story constantly. A person spends years — sometimes a decade — describing real, disruptive, life-altering symptoms to providers, and is told, in one form or another, that it’s stress. That it’s in their head. That their labs are normal, so nothing is actually wrong.

One client of mine lived with bloating, cramping, and unpredictable bowel symptoms for eight years. Eight years of being told to relax, to try yoga, to consider that anxiety was driving her gut, not the other way around. She was gaslit — there is really no gentler word for it — by well-meaning providers who ran the tests they knew how to run, found nothing on those specific tests, and concluded the problem must be psychological rather than concluding the problem simply hadn’t been measured yet.

When we finally ran her MRT, her results showed significant reactivity to several foods she ate almost daily. Within weeks of following her personalized LEAP protocol, her digestive symptoms — the same ones she’d been told for nearly a decade were “just stress” — were gone. Not managed. Gone. She wasn’t anxious about her gut. Her gut had been inflamed the entire time, and the tools being used to look for the problem simply weren’t built to see it.

I want to be careful here, because this matters: her anxiety was real, and stress absolutely can affect the gut — the gut-brain connection is well established, and I take it seriously in every client I see. But “it’s stress” cannot be where the workup stops. It has to be one hypothesis among several, tested rather than assumed, especially when a person has already told you, repeatedly and clearly, that something in their body feels wrong.

For a deeper look at the mechanisms behind this — how food-triggered inflammation drives gut symptoms that standard testing misses — I’ve written extensively about it in my comprehensive leaky gut diet guide, including my own MRT results and the specific foods that turned out to be driving my own inflammation.

The Migraine Pattern I Can No Longer Call a Coincidence

I don’t say this lightly, because I know how big a claim it sounds like: in my own clinical practice, the majority of clients I have worked with who came to MRT/LEAP specifically for chronic migraines have seen their migraines resolve or become dramatically less frequent — including my own. I lived with migraines for years before I understood that specific foods in my own “healthy” diet were quietly triggering them. Once I removed my personal reactive foods, they stopped. I’ve written more broadly about root-cause approaches to migraines — including nutrient deficiencies and other triggers beyond food sensitivity — in my natural migraine remedies guide.

I’m not claiming this happens for everyone, or that food sensitivity is the cause of every migraine — migraines are complex, and hormonal, vascular, and neurological factors all play a role, and I always want clients working with a neurologist or headache specialist alongside this work. But the consistency of this pattern, across many clients, is not something I can responsibly ignore. Chronic mediator release from reactive foods is a known driver of vascular and inflammatory symptoms, and histamine release in particular — the kind I cover in depth in my anti-histamine foods and meal plan guide — is one of the most common triggers I see behind migraine, brain fog, and unexplained flushing. Migraine is one of the conditions most frequently cited in the MRT/LEAP literature for exactly that reason.

When something works this reliably, this many times, in this many different people — that repetition is itself a form of evidence. Clinicians have used observed, replicated patterns to guide care since long before the randomized controlled trial existed. We didn’t stop doing that because RCTs were invented. We just stopped valuing it as much as we should.

The Weight Loss Nobody Had to Try For

There’s a pattern I’ve watched repeat itself so consistently across my career that I no longer think of it as anecdotal — I think of it as data I simply haven’t formally published. LEAP isn’t a weight-loss program, and I don’t market it as one. But in my career, I honestly cannot think of a client who wanted to lose weight while following their LEAP protocol and didn’t. Not through restriction, not through tracking, not through eating less — through eating abundantly from a list built around what their own body actually tolerated.

I’m experiencing this myself, right now. I’m not restricting calories, I’m not counting anything, and I’m certainly not eating less — if anything, I’m eating more generously than I had in years, simply eating foods that work for my body instead of quietly working against it. I’ve lost ten pounds without effort, and the weight is still continuing to come off.

I don’t think that’s a coincidence, and I don’t think it’s really about willpower or intake at all. My working theory, built from watching this happen over and over, is that it’s about hormones. Chronic inflammation disrupts hormone signaling throughout the body — insulin sensitivity, cortisol regulation, thyroid hormone conversion, and the appetite and satiety hormones, like leptin and ghrelin, that are supposed to tell the brain when enough is enough. When that signaling is impaired by ongoing immune activation, the body tends to hold onto weight defensively, regardless of how disciplined a person is being. Calm the inflammation, and in case after case, the signaling — and the weight — follows. I’ve written more specifically about this inflammation-weight connection, including how a single common food can quietly drive it, in my post on how gluten intolerance can cause weight gain through inflammation. I believe this broader mechanism deserves far more formal research attention than it currently gets, and it’s exactly the kind of root-cause connection that gets lost when conversations about weight stay fixated only on calories in versus calories out.

What the Research Actually Shows

I want to be honest about where MRT sits in the evidence landscape, because I think honesty is what builds trust — not overstatement in either direction. MRT is not universally endorsed by major allergy and immunology bodies, and it is not a diagnostic test for any specific disease; I say that clearly with every client I work with. Some professional groups have declined to formally endorse it, largely because the published evidence base is smaller in scale than what they require before issuing a blanket recommendation — the same population-level standard this entire post is questioning.

But “smaller in scale” does not mean “absent.” What it is: a patented, reproducible lab measurement of mediator release from white blood cells that tests reactivity to both whole foods and hidden inflammatory food chemicals, with published sensitivity and specificity data, and a growing body of individual case reports and small clinical studies — exactly the kind of evidence that tends to get dismissed by anyone waiting for a ten-thousand-person trial, and exactly the kind of evidence that matters most to the specific person sitting outside the bell curve. Here is some of what’s actually been published:

And while I’m being honest about evidence, I want to name something that rarely gets said out loud: a great deal of the population-level nutrition data used to define “normal” eating — the data behind many of the large studies that shape official guidance — comes from food recall and food frequency data collected decades ago. In 26 years of clinical practice, I have not met a single client who eats the way people ate when many of those landmark studies were conducted. Food availability has changed. Ultra-processed food exposure has changed dramatically. Preferences, agricultural practices, and even the chemical makeup of common ingredients have shifted. Treating multi-decade-old dietary recall data as a precise blueprint for how a person should eat today isn’t rigorous science — it’s outdated data wearing the costume of certainty, and it deserves far more scrutiny than it usually gets.

A documented pediatric Crohn’s remission. A case report published in Alternative Therapies in Health and Medicine and indexed on PubMed followed a 12-year-old boy with Crohn’s ileocolitis and gastritis who had not responded to over ten months of standard treatment. After 39 days on a LEAP protocol built from his mediator release results, his fecal calprotectin — an objective marker of intestinal inflammation — dropped from over 2,000 μg/g to 185.9 μg/g. A follow-up endoscopy with ten biopsies one year later showed complete histologic remission. This isn’t a symptom questionnaire. It’s a biopsy.

A diarrhea-predominant IBS study. Ten patients meeting Rome II criteria for D-IBS, evaluated by a gastroenterologist at a community GI practice and published in the Journal of the Academy of Nutrition and Dietetics, followed a LEAP MRT-based elimination diet. Average symptom survey scores fell from 56.9 to 26.3 overall, and the GI-specific portion fell from 19.1 to 6.3, after at least one month on the protocol — roughly a 55% overall reduction in a condition frequently described in conventional medicine as having no treatment that reliably improves global symptoms. If IBS-D is part of your own story, I’ve written more about targeted fiber and gut-support strategies in my best fiber supplement for IBS-D guide.

A migraine study. Linke, Zarini, McLean, Hogan, Hogan, and Patenaude published “Tailored Dietary Approach for Individuals with Migraine” in Current Developments in Nutrition (2021) — direct research support for the exact pattern I’ve watched repeat itself in my own clients and in my own body.

A fibromyalgia study. Patenaude, Zarini, McLean, and Linke published “Effectiveness of a Tailored Dietary Program in Subjects with Fibromyalgia” in the same journal issue (2021).

A PCOS pilot study. Braunstein, Hogan, and Diaz Escamilla published “The Lifestyle Eating and Performance (LEAP) Program for Improving Quality of Life in Women With PCOS: A Pilot Study of Dietitian-Directed Therapy,” also in Current Developments in Nutrition (2021) — relevant for the number of women told their PCOS symptoms, including weight gain, are simply a matter of eating less and moving more.

A hidradenitis suppurativa pilot study. Ceresnie, Ondreyka, Ezekwe, Zarini, McLean, and Hamzavi ran a prospective pilot study on LEAP outcomes in HS patients, presented at both the AMA Research Challenge and the Symposium on Hidradenitis Suppurativa Advances in 2022 — a painful, chronic inflammatory skin condition that, like so much on this list, is driven by immune activation conventional workups rarely trace back to food. You can find this study alongside the others referenced here on Oxford Biomedical Technologies’ published research page.

The foundational multi-condition paper. Patenaude and Bright’s “Clinical Improvement of IBS, Migraine, Fibromyalgia and Arthritis Using Elimination Diets Based on Mediator Release Blood Testing” is the paper much of this later work builds on, and it’s the closest thing this field has to an anchor citation spanning multiple diagnoses at once.

None of these are large-scale, thousand-patient randomized trials. I won’t pretend otherwise, and I’d rather you hear that from me than discover it later and lose trust in everything else I’ve told you. But look at what they have in common: real patients, objective and subjective measures, published in indexed journals, across seven completely different diagnoses — Crohn’s, IBS, migraine, fibromyalgia, PCOS, hidradenitis suppurativa, arthritis — all showing the same pattern. That degree of consistency, across that many conditions, is not nothing. It’s exactly the kind of evidence a population-average trial is too slow, too expensive, and too broad to ever fully capture — and exactly the kind of evidence that matters most if you are one of the people the bell curve was never built to describe.

The Movement Away From Average Medicine

I’m far from the only clinician pushing on this. Physicians like Mark Hyman have spent years building the case, in books, in clinics, and now in consumer health platforms, that root-cause and functional approaches deserve a real seat next to conventional care — not as an alternative to evidence, but as a way of applying evidence at the level of the individual instead of only the population. Practitioners like Alan Christianson and Aviva Romm have built entire careers on the same core idea: listen first, test what conventional medicine doesn’t routinely test, and treat the person rather than the diagnosis code.

This isn’t anti-science. It’s a different question than the one conventional medicine usually asks. Conventional medicine asks, “What does the average patient with this diagnosis need?” Functional medicine asks, “What does this specific patient’s body need, and how do we find out?” Both questions matter. But for the millions of people who don’t respond the way the average patient responds, only one of those questions actually helps them.

Minimal Risk, Meaningful Benefit — Why We Don’t Wait for Ten Trials

Here is the clinical calculus I actually use, and I think every practitioner working this way uses some version of it: when an intervention carries very low risk of harm, is grounded in a plausible and partially validated mechanism, and has shown consistent benefit across the patients I’ve personally treated, I don’t need to wait for a decade of large-scale trials before offering it to someone who is suffering right now.

That trial, if it ever gets funded and run, will tell us what happens to the average person in it. It was never going to tell us what happens to you. You don’t have ten years to wait for population-level proof of what your own body has already shown you, in your own symptoms, your own labs, your own life. Good clinical care means weighing risk against benefit for the person in the room — not waiting for permission from a study that wasn’t designed with that person in mind in the first place. It’s the same reasoning I bring to the broader gut-healing work I do with clients: start with what’s low-risk and well-reasoned, and let the person’s own response guide the next step.

Your Labs Are Normal But You Still Feel Sick — Here’s What That Actually Means

If you’ve been told your labs are normal while you feel far from it — if you’ve been told to just relax, just eat less, just manage your stress — I want you to hear this clearly: your experience is data too. It may not fit in a p-value, but it is real, and it deserves to be investigated rather than dismissed.

You are allowed to ask for more testing. You are allowed to ask why a symptom that disrupts your life is being explained away instead of explored. You are allowed to seek out a clinician who treats “I don’t feel right” as a starting point for investigation, not an inconvenience to be managed with reassurance. Population averages are a tool, not a verdict on your particular body. You don’t have to be average to deserve real answers — and small, practical steps like the ones in my gut health superfoods guide are a reasonable place to start while you advocate for the deeper testing you deserve.

And MRT is only one piece of that deeper testing. It’s simply the one I have the most personal and clinical experience with, and the one that’s given me the most consistent results across the widest range of conditions. But if you’ve genuinely done everything right — the diet, the exercise, the sleep, the stress management, every conventional test your doctor could order — and you are still struggling with your weight or with a debilitating condition that no one can explain, MRT is one of several functional labs worth exploring, not the only one. A GI-MAP stool test can uncover gut infections, parasites, and dysbiosis that standard stool cultures miss entirely. Mold and mycotoxin testing can reveal an environmental exposure driving inflammation that has nothing to do with diet at all. Lyme and tick-borne illness testing, done through a lab that understands its real limitations, can surface an infection that’s been quietly driving fatigue and pain for years. Advanced nutrition panels can catch functional deficiencies long before they show up as a deficiency on a standard basic metabolic panel. Advanced thyroid panels are another one that shouldn’t be ignored — most conventional workups stop at TSH, and sometimes T4, when a full picture of T3, reverse T3, and thyroid antibodies is often what’s actually needed to explain fatigue, weight gain, and hormone symptoms that get written off as normal. And if cardiovascular risk is part of your picture, an advanced lipid panel — looking at particle number and size, not just total cholesterol and LDL — tells a far more meaningful story than the standard panel most people are given and told is “normal.”

The common thread across all of it is the same one running through this entire post: the standard workup was built to catch what’s common in the average patient. It was never built to catch what’s happening in you. If you’re still suffering after doing everything conventional medicine asked of you, the answer usually isn’t that you need to try harder. It’s that no one has ordered the right test yet.

Frequently Asked Questions

Is MRT/LEAP a replacement for medical care?
No. MRT/LEAP is a functional nutrition tool for identifying food-triggered inflammation. It is not a diagnostic test for any disease and should be used alongside, not instead of, care from your physician or specialist.

Why haven’t I heard about MRT from my doctor?
Most conventional providers are trained around IgE allergy testing and standard lab panels, which don’t measure the mediator-release pathway MRT is designed to capture. It’s a gap in training and scope, not necessarily a judgment that the tool doesn’t work.

Does MRT help with weight loss?
For clients whose weight struggles are driven by underlying inflammation rather than intake alone, removing personal reactive foods can support more natural, sustainable weight change. It is not a weight-loss test on its own, and it works best as part of a full clinical picture.

How is this different from just doing an elimination diet?
A generic elimination diet removes commonly reactive foods for everyone. MRT measures your own immune response to 170+ specific foods and chemicals, so the plan is built around your actual reactive foods rather than a population-level guess.

Why does my doctor say it’s just stress?
Most conventional workups reasonably rule out the more common or dangerous causes first, and when standard tests come back clear, stress becomes the default explanation. It can be a real factor, but it shouldn’t be the only hypothesis tested — especially for symptoms that have persisted for years.

Why won’t my doctor test for food sensitivities?
Food sensitivity testing like MRT falls outside standard medical training and isn’t part of routine primary care panels, so most physicians simply don’t have it in their toolkit — not because they’ve ruled it out, but because it was never part of their workup to begin with.

What other functional labs should I consider besides MRT?
MRT is one piece of a larger picture. Depending on your symptoms, a GI-MAP stool test, mold or mycotoxin testing, Lyme and tick-borne illness testing, advanced nutrition panels, advanced thyroid panels (T3, reverse T3, and thyroid antibodies rather than just TSH), and advanced lipid testing can all uncover drivers that standard conventional labs miss.